Core Viewpoint - Zhenqu Technology has submitted its listing application to the Hong Kong Stock Exchange, with CITIC Securities and Guotai Junan as joint sponsors. The company focuses on electric vehicle (EV) control solutions and has developed a layered solution set that includes power modules, motor controllers, and power bricks, allowing customers to choose different levels of system integration [1] Group 1: Company Overview - Zhenqu Technology pioneered the concept of "power brick" and achieved mass production of the main drive power brick in 2021, significantly simplifying the assembly of control systems, enhancing platform reusability, and shortening development cycles [1] - The company has expanded its offerings to low-power controllers and domain controllers in the power domain and chassis domain [1] Group 2: Market Position and Achievements - As of September 30, 2025, the company has secured 50 design wins from 13 OEMs, with solutions applied to 82 vehicle models, 54 of which have entered mass production [1] - According to Frost & Sullivan, the company's rankings in the Chinese market by installation volume are as follows: - Motor controllers ranked 11th in 2024 and 8th in the first nine months of 2025 - Dual motor controllers ranked 3rd in the first nine months of 2025 - Main drive power bricks ranked 1st in 2024 and 2nd in the first nine months of 2025 - Power bricks installed in dual motor controllers ranked 1st in the first nine months of 2025 - Power modules ranked 8th in 2024 and 7th in the first nine months of 2025 [1] Group 3: Business Expansion - The company has leveraged its core technology to expand its business into emerging fields such as electric vertical takeoff and landing vehicles (eVTOL) and embodied intelligence [1]

Group 1 - Company has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the exclusive sponsor [1] - Company is a research-driven biopharmaceutical firm based in China, focusing on significant unmet medical needs in oncology, autoimmune diseases, and metabolic diseases [1] - As of December 24, 2025, the company has established a comprehensive and differentiated product pipeline, including two commercialized products, two core products in clinical stages, one candidate in clinical stage, and three candidates in preclinical stage [1] Group 2 - The commercialized products include BPI-D0316, a third-generation EGFR tyrosine kinase inhibitor for EGFR mutation-positive non-small cell lung cancer (NSCLC), which has been approved and included in the National Medical Insurance Drug List in China [1] - Another commercialized product, D-1553, is a KRAS G12C inhibitor, the first self-developed product in this target area to enter clinical stages in China, also approved and included in the National Medical Insurance Drug List [1] - The company has signed an agreement with Zhengda Tianqing to grant exclusive rights for the development, registration, production, and commercialization of D-1553 in mainland China [1] Group 3 - The core clinical-stage product D-2570 is undergoing a registrational Phase III clinical trial for plaque psoriasis and ulcerative colitis (UC), with plans to initiate additional trials for psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), and vitiligo [2] - Tairisig is an oral selective estrogen receptor degrader (SERD) currently in a registrational Phase III clinical trial for ER+/HER2- breast cancer [2] - The global and Chinese markets for oncology drugs, targeted oncology drugs, psoriasis drugs, UC drugs, and SERD drugs show significant growth potential, with the Chinese targeted oncology drug market expected to reach $61.6 billion by 2035 [2]

Group 1 - The core viewpoint is that 2026 will be a crucial year for China's economic work, marking the beginning of the "15th Five-Year Plan" and the transition to a period of solid foundation and comprehensive efforts [1] - Analysts from ten major securities firms provide insights on market trends, industry allocations, and major investment opportunities for 2026, aiming to clarify the investment landscape for investors [1] Group 2 - CITIC Securities predicts that A-share company profit growth will show a trend of low growth initially followed by a recovery [2] - The market is expected to be influenced by the US-China trade agreement and the US midterm elections, with three phases of market performance anticipated [4] - Key investment themes include global pricing power in manufacturing, the expansion of Chinese companies overseas, the continuation of the tech trend with AI, and the potential recovery of domestic demand [4] Group 3 - CICC highlights that the restructuring of international order and China's industrial innovation will support A-share performance, with a market trend of initial growth followed by stabilization [5] - Analysts suggest focusing on growth sectors such as AI applications, industries benefiting from external demand, and cyclical sectors nearing recovery [7] Group 4 - GF Securities indicates that the A-share market is likely to maintain a "slow bull" pattern, with corporate profit structures undergoing significant changes [8][10] - The expected nominal GDP growth for China in 2026 is projected to reach 6.45%, significantly higher than in 2025, supporting the overall improvement in corporate profits [21] Group 5 - Analysts from various firms suggest that the market will shift from valuation-driven to profit-driven dynamics, with traditional and emerging industries contributing to profit recovery [15][17] - The focus on new production capabilities and the impact of policies like "anti-involution" are expected to improve competition in traditional industries and boost domestic demand [17] Group 6 - Analysts predict that more industries will enter a profit recovery phase in 2026, with nominal economic recovery and price increases being the most evident trends [18][20] - UBS forecasts that A-share company profit growth could rise to 8% due to improved nominal GDP growth and the narrowing of PPI declines [32] Group 7 - Analysts recommend focusing on four main investment themes: technological self-reliance, consumer sector recovery, "anti-involution" related sectors, and the global competitiveness of Chinese companies [34] - The market is expected to maintain a balanced style between growth and value, with cyclical sectors likely to outperform defensive sectors as the economy recovers [34]

Core Viewpoint - The analysis highlights the expected trends and investment opportunities in the A-share market for 2026, emphasizing a shift towards profitability-driven growth amid a recovering economy and evolving global dynamics [1][28]. Group 1: Economic Outlook - 2026 marks the beginning of the "15th Five-Year Plan," focusing on solidifying foundations and comprehensive efforts for economic modernization [1][28]. - The A-share market is anticipated to experience a recovery in corporate profitability, with a projected increase in earnings growth to 8% driven by improved nominal GDP growth and narrowing PPI declines [53][52]. Group 2: Market Phases - The market is expected to be segmented into three phases influenced by U.S.-China trade agreements and U.S. midterm elections, with a potential for sustained growth in a stable external environment [3][30]. - Analysts predict a "slow bull" market pattern, with corporate profitability stabilizing and the return of investment interest from insurance and high-net-worth individuals [7][34]. Group 3: Investment Themes - Key investment themes include: - The manufacturing sector's pursuit of global pricing power, particularly in non-ferrous metals, chemicals, and new energy [3][30]. - The globalization of Chinese enterprises, opening up new market opportunities in machinery, innovative pharmaceuticals, and military industries [3][30]. - Continued growth in the AI sector, with a focus on semiconductors, computing power, and AI applications [3][30]. - Recovery opportunities in domestic demand, particularly in sectors with potential for valuation elasticity [3][30]. Group 4: Sector Focus - Analysts suggest focusing on sectors with clear growth trends, such as AI, where capital expenditure is expected to expand, and cyclical industries like chemicals and renewable energy that may benefit from policy support [5][38]. - The technology sector is projected to maintain high profit growth, although the valuation gap with traditional sectors may pose challenges [40][42]. Group 5: Policy and Market Dynamics - The market is expected to transition from valuation-driven to profitability-driven dynamics, supported by fiscal policies aimed at boosting domestic demand and improving competition in traditional industries [38][40]. - Analysts emphasize the importance of capital market reforms to enhance flexibility and attract long-term investments, particularly in emerging industries [45][48].

Core Viewpoint - The article discusses the outlook for the A-share market in 2026, emphasizing the importance of economic work and investment strategies as China enters a critical period of its "14th Five-Year Plan" [1][2]. Group 1: Market Trends and Economic Outlook - A-share company profit growth is expected to show a "low first, high later" trend in 2026, influenced by the US-China trade dynamics and the upcoming US midterm elections [3][5]. - The international order's restructuring and China's industrial innovation are anticipated to support A-share performance, with a market trend of initial growth followed by stabilization [6][8]. - The nominal GDP growth in China is projected to reach 6.45% in 2026, significantly higher than in 2025, indicating a recovery in corporate earnings [21]. Group 2: Investment Opportunities and Sector Focus - Key investment themes include the global pricing power in manufacturing, the expansion of Chinese companies overseas, the continuation of the tech trend with AI, and the potential recovery in domestic demand [5][8][19]. - Analysts suggest focusing on sectors with clear growth trends, such as AI applications, machinery, innovative pharmaceuticals, and energy equipment [5][8][19]. - The A-share market is expected to maintain a "slow bull" pattern, with a focus on industries experiencing supply constraints and clear growth trends, such as AI and energy storage [11][25]. Group 3: Policy and Structural Changes - The article highlights the need for policies that support long-term market stability and the development of new industries, particularly in technology and innovation [6][17][24]. - The "anti-involution" policies are expected to improve competition in traditional industries and stimulate domestic demand, contributing to overall market recovery [15][17]. - The capital market is anticipated to transition from valuation-driven to profit-driven dynamics, with a focus on sectors that can benefit from both traditional and emerging growth drivers [15][19].

Core Insights - The capital market showed a positive trend in 2025, with active trading reflected in the significant increase in transaction volume on the Longhu list, reaching 3.34 trillion yuan, a year-on-year growth of over 40% [1][2] - The competition among brokerage firms intensified, with notable changes in the rankings of the top 100 brokerage departments, highlighting the emergence of several "dark horse" firms [1][3] Group 1: Market Performance - In 2025, a total of 7,029 brokerage departments appeared on the Longhu list 123,900 times, with a total transaction volume of 3.34 trillion yuan, marking a 42.6% increase year-on-year [2] - The top 100 brokerage departments accounted for 2.26 trillion yuan of the total transaction volume, representing 67.66% of the market share, indicating a strong head effect [2] Group 2: Top Brokerage Departments - The "Lhasa team" under Dongfang Caifu Securities maintained a strong performance, occupying three of the top ten positions, with the Lhasa Tuanjie Road No. 1 Securities Department leading with a transaction volume of 127.87 billion yuan [2] - New entrants to the top ten include Kaiyuan Securities' Xi'an Xidajie Securities Department, which rose from 27th place in 2024 to 3rd in 2025, and several other firms that significantly improved their rankings [2][3] Group 3: Emerging Firms and Foreign Participation - Several "dark horse" brokerage departments made significant leaps in rankings, such as Guotai Junan's Shanghai Jing'an District New Zha Road Securities Department, which rose from 559th to 14th place [3] - The presence of foreign brokerage firms is increasing, with six foreign brokerage departments making it into the top 50, including UBS and Goldman Sachs, showcasing their growing influence in the market [4] Group 4: Industry Trends - The competition in brokerage business has intensified, reflecting differences in client scale, market share, and overall strength among various firms, as well as the strategic focus on regional development by branch offices [5] - The Longhu list serves as an important indicator of market sentiment and hotspots, with sectors like general equipment, chemical products, computer software, automotive, and semiconductors attracting significant investment [6]

关于部分控股股东及其一致行动人 进行质押式回购交易 展期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 浙江华康药业股份有限公司（以下简称"公司"）部分控股股东及其一致行动人程新平先生、徐小荣先 生和余建明先生分别持有公司16,685,055股、15,691,337股、13,143,335股,分别占总股本的5.51%、 5.18%、4.34%。本次程新平先生、徐小荣先生和余建明先生将各自部分持有股份中的9,000,000股、 9,500,000股、7,000,000股质押给中信证券股份有限公司（以下简称"中信证券"），本次股份质押展期业 务完成后，其质押股份共计25,500,000股，占公司总股本8.41%。 一、上市公司股份质押 证券代码：605077 证券简称：华康股份 公告编号：2025-100 债券代码：111018 债券简称：华康转债 浙江华康药业股份有限公司 公司近日接到部分控股股东及其一致行动人程新平先生、徐小荣先生、余建明先生的通知，获悉上述人 员与中信证券办理了股票质押式回购 ...

Core Viewpoint - The chief A-share strategist of CITIC Securities, Qiu Xiang, predicts that the profit growth rate of A-share companies will show a trend of low-to-high from 2026 onwards, influenced by the dynamics of the China-US relationship [1] Summary by Categories Market Phases - The market is expected to be divided into three phases based on the China-US trade agreement and the US midterm elections: 1. The first phase is from now until the trade agreement is finalized, where market growth is expected to slow down 2. The second phase is from the agreement's implementation until the midterm elections, where A-shares may experience sustained growth in a stable external environment 3. The third phase follows the midterm elections, where uncertainties from external disturbances may increase, prompting investors to refocus on domestic markets [1] Investment Opportunities and Sector Allocation - Four major themes are highlighted for investment opportunities: 1. The manufacturing sector's competition for global pricing power, with a focus on industries such as non-ferrous metals, chemicals, and new energy, which can convert market share advantages into pricing power and profit margin increases 2. The globalization of Chinese enterprises, which significantly expands market capitalization and profit growth potential, with key industries including machinery, innovative pharmaceuticals, power equipment, and military industry 3. The continuation of the technology trend, particularly in AI, which is expected to further expand its commercial applications and enhance the competitive advantages of Chinese companies, focusing on sectors like semiconductors, computing power, edge hardware, and AI applications 4. The potential for unexpected recovery in domestic demand, where despite general industry conditions being average, there exists significant room for recovery and valuation elasticity in domestic demand-sensitive sectors [1]

Group 1 - The core viewpoint is that CITIC Securities maintains a solid industry leadership position, with comprehensive strength leading across capital scale, business coverage, and brand influence [3][16][17] - The company leverages the strong resources of its major shareholder, CITIC Group, sharing financial licenses and benefiting from a global industrial layout and client network, creating a "finance + industry" synergy [3][17] - The management team demonstrates top-tier strategic foresight, establishing a development path that balances expansion during economic upturns and building barriers during downturns, maintaining a leading advantage amid industry cyclicality [3][17] Group 2 - The operating performance is steadily improving, with strong profitability and risk control capabilities, as CITIC Securities is the first domestic brokerage to exceed total assets of 2 trillion yuan, showcasing absolute capital strength and efficient capital operation [2][4][17] - A balanced and diversified business structure supports the company's resilience through market cycles, with most main business revenue scales ranking first in the industry, highlighting comprehensive competitive strength [2][4][17] - The company has established a "multi-engine drive" model for performance growth, effectively countering cyclical market risks and providing solid support for sustainable operational development [2][4][17] Group 3 - Key breakthroughs in core areas are evident, with significant progress in wealth management transformation, moving from traditional brokerage to a modern asset allocation platform, gradually building a global asset allocation ecosystem [4][18] - The cross-border investment banking business remains a leader, enhancing international competitiveness and service coverage in areas such as overseas equity financing and cross-border mergers and acquisitions [4][18] - The asset management business is deepening its active management transformation, optimizing asset structure, and accelerating innovative asset management initiatives [4][18] Group 4 - In the context of deepening domestic capital market reforms and tightening regulations, the "Matthew effect" in the securities industry is becoming more pronounced, with leading brokerages expected to continue capturing market share [5][19] - As an industry leader, CITIC Securities not only excels in scale and performance but also continues to make breakthroughs in high-quality development areas such as wealth management and cross-border investment banking, forming sustainable growth momentum [5][19]

Core Insights - The report highlights that the public fund fee reform has concluded, and insurance companies are expected to perform well, indicating potential investment opportunities in the spring market [1][6]. Group 1: Industry Performance - As of December 31, 2025, the Shanghai Composite Index closed at 3968.84 points, up 0.13%, while the Shenzhen Component Index fell by 0.58% [11]. - The average daily trading volume in the Shanghai and Shenzhen markets reached 2.13 trillion yuan, an increase of 8.30% week-on-week [6]. Group 2: Insurance Sector - Insurance companies are anticipated to maintain high growth in performance, with short-term results expected to exceed expectations and long-term interest rate spreads likely to improve [17]. - The Ministry of Finance released a draft revision of the accounting standards, enhancing the clarity of profit sources for insurance companies and improving comparability across industries [17]. - Key stocks to watch in the insurance sector include China Ping An, China Life, and New China Life, among others [17]. Group 3: Securities Sector - The public fund fee reform is expected to save investors approximately 51 billion yuan annually, with a fee reduction of about 20% [18]. - The reform includes differentiated redemption fee structures aimed at promoting long-term investment and reducing short-term trading behaviors [19]. - The introduction of new REITs regulations is expected to enhance the market's quality and expand opportunities for securities firms [24][28]. Group 4: Valuation and Financial Analysis - China Ping An (601318.SH) has a target price of 85.17 yuan, with an estimated EPS of 8.91 yuan for 2025, reflecting a PE ratio of 7.68 [7]. - New China Life (601336.SH) has a target price of 94.21 yuan, with an estimated EPS of 14.04 yuan for 2025, indicating a PE ratio of 4.96 [7]. - The report suggests that the valuation metrics for various companies in the sector indicate potential upside, with several stocks rated as "Buy" [7].